OpenAI · 2026-05-29 · major
OpenAI Launches Rosalind Biodefense — Sponsored GPT-Rosalind Access for Trusted Pandemic-Prep Developers and US/Allied Governments, With Lawrence Livermore, Johns Hopkins APL, CEPI, Fourth Eon, and SecureDNA Onboard
OpenAI opens its life-sciences reasoning model GPT-Rosalind to vetted biodefense developers and government partners through a sponsored Trusted Access program, with Lawrence Livermore, Johns Hopkins APL, CEPI, Fourth Eon, and SecureDNA as first cohort.
OpenAI hands its biology-tuned reasoning model GPT-Rosalind to vetted biodefense teams and governments, free of charge, for pandemic-prep work.
What is it?
Rosalind Biodefense is a new OpenAI program that gives sponsored, vetted access to GPT-Rosalind — the company's life-sciences reasoning model first introduced in April — for biodefense, pandemic preparedness, and public-health workflows. It runs as a Trusted Access channel: qualified organizations apply, OpenAI sponsors GPT-Rosalind use and provides launch support, and applicants worldwide can build defensive applications on top.
How does it work?
GPT-Rosalind reasons over molecules, proteins, genes, pathways, and disease biology rather than serving as a general chatbot. Through Rosalind Biodefense, qualified teams plug it into early-detection systems, outbreak response planning, diagnostics, biosurveillance, and medical-countermeasure development. Launch partners Lawrence Livermore National Laboratory, Johns Hopkins Applied Physics Laboratory, and the Coalition for Epidemic Preparedness Innovations (CEPI) are using the model for biopreparedness, protein engineering, and vaccine development; Fourth Eon and SecureDNA are using it for DNA screening. OpenAI is also extending trusted access for select US government and allied partners with approved public-health and biodefense missions.
Why does it matter?
It is the first time OpenAI has fenced off a frontier domain-specific model behind a vetted public-health channel instead of selling it commercially or open-sourcing it. If trusted access actually compresses the time from outbreak detection to countermeasure deployment, biodefense becomes an early test of whether 'GPT-but-for-biology' delivers real-world leverage. It also gives OpenAI a sanctioned line into US biosecurity work after months of biorisk-policy debate around frontier models.
Who is it for?
biodefense developers, government public-health teams, vaccine and diagnostics researchers, biosurveillance programs
Try it
Apply: https://openai.com/form/rosalind-biodefense-program/